Reaction
Heart Failure With Reduced Ejection Fraction reporting signals
As of the last recalculation, Heart Failure With Reduced Ejection Fraction appears in 451 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is LINAGLIPTIN (PRR 33.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Linagliptin | 13 | 33.8 | 33.9 |
| Eplerenone | 9 | 33.1 | 33.1 |
| Dapagliflozin | 19 | 29.1 | 29.1 |
| Fam-Trastuzumab Deruxtecan-Nxki | 6 | 27.8 | 27.8 |
| Tafamidis | 5 | 19.8 | 19.8 |
| Oxaliplatin | 29 | 19.2 | 19.2 |
| Pemetrexed | 8 | 17.5 | 17.5 |
| Olaparib | 5 | 11.1 | 11.1 |
| Sacubitril And Valsartan | 26 | 10.9 | 10.9 |
| Osimertinib | 7 | 10.2 | 10.2 |